Altitude Training and Recombinant Human Erythropoietin: Considerations for Doping Detection

Shaun Sutehall, Borja Muniz-Pardos, Giscard Lima, Guan Wang, Fernanda Rossell Malinsky, Andrew Bosch, Irina Zelenkova, Kumpei Tanisawa, Fabio Pigozzi, Paolo Borrione, Yannis Pitsiladis

研究成果: Article

抄録

The benefit of training at altitude to enhance exercise performance remains equivocal although the most widely accepted approach is one where the athletes live and perform lower-intensity running at approximately 2300 m with high-intensity training at approximately 1250 m. The idea is that this method maintains maximal augmentations in total hemoglobin mass while reducing the performance impairment of high-intensity sessions performed at moderate altitude and thus preventing any detraining that can occur when athletes live and train at moderate altitude. This training regimen, however, is not universally accepted and some argue that the performance enhancement is due to placebo and training camp effects. Altitude training may affect an athlete's hematological parameters in ways similar to those observed following blood doping. Current methods of detection appear insufficient to differentiate between altitude training and blood doping making the interpretation of an athlete's biological passport difficult. Further research is required to determine the optimal method for altitude training and to enhance current detection methods to be able to differentiate better blood doping and altitude exposure.

元の言語English
ページ(範囲)97-104
ページ数8
ジャーナルCurrent Sports Medicine Reports
18
発行部数4
DOI
出版物ステータスPublished - 2019 4 1

Fingerprint

Erythropoietin
Doping in Sports
Athletes
Running
Hemoglobins
Placebos
Exercise
Research

ASJC Scopus subject areas

  • Orthopedics and Sports Medicine
  • Public Health, Environmental and Occupational Health

これを引用

Sutehall, S., Muniz-Pardos, B., Lima, G., Wang, G., Malinsky, F. R., Bosch, A., ... Pitsiladis, Y. (2019). Altitude Training and Recombinant Human Erythropoietin: Considerations for Doping Detection. Current Sports Medicine Reports, 18(4), 97-104. https://doi.org/10.1249/JSR.0000000000000577

Altitude Training and Recombinant Human Erythropoietin : Considerations for Doping Detection. / Sutehall, Shaun; Muniz-Pardos, Borja; Lima, Giscard; Wang, Guan; Malinsky, Fernanda Rossell; Bosch, Andrew; Zelenkova, Irina; Tanisawa, Kumpei; Pigozzi, Fabio; Borrione, Paolo; Pitsiladis, Yannis.

:: Current Sports Medicine Reports, 巻 18, 番号 4, 01.04.2019, p. 97-104.

研究成果: Article

Sutehall, S, Muniz-Pardos, B, Lima, G, Wang, G, Malinsky, FR, Bosch, A, Zelenkova, I, Tanisawa, K, Pigozzi, F, Borrione, P & Pitsiladis, Y 2019, 'Altitude Training and Recombinant Human Erythropoietin: Considerations for Doping Detection' Current Sports Medicine Reports, 巻. 18, 番号 4, pp. 97-104. https://doi.org/10.1249/JSR.0000000000000577
Sutehall, Shaun ; Muniz-Pardos, Borja ; Lima, Giscard ; Wang, Guan ; Malinsky, Fernanda Rossell ; Bosch, Andrew ; Zelenkova, Irina ; Tanisawa, Kumpei ; Pigozzi, Fabio ; Borrione, Paolo ; Pitsiladis, Yannis. / Altitude Training and Recombinant Human Erythropoietin : Considerations for Doping Detection. :: Current Sports Medicine Reports. 2019 ; 巻 18, 番号 4. pp. 97-104.
@article{89bfc92735744b2cacb79a680abc4a55,
title = "Altitude Training and Recombinant Human Erythropoietin: Considerations for Doping Detection",
abstract = "The benefit of training at altitude to enhance exercise performance remains equivocal although the most widely accepted approach is one where the athletes live and perform lower-intensity running at approximately 2300 m with high-intensity training at approximately 1250 m. The idea is that this method maintains maximal augmentations in total hemoglobin mass while reducing the performance impairment of high-intensity sessions performed at moderate altitude and thus preventing any detraining that can occur when athletes live and train at moderate altitude. This training regimen, however, is not universally accepted and some argue that the performance enhancement is due to placebo and training camp effects. Altitude training may affect an athlete's hematological parameters in ways similar to those observed following blood doping. Current methods of detection appear insufficient to differentiate between altitude training and blood doping making the interpretation of an athlete's biological passport difficult. Further research is required to determine the optimal method for altitude training and to enhance current detection methods to be able to differentiate better blood doping and altitude exposure.",
author = "Shaun Sutehall and Borja Muniz-Pardos and Giscard Lima and Guan Wang and Malinsky, {Fernanda Rossell} and Andrew Bosch and Irina Zelenkova and Kumpei Tanisawa and Fabio Pigozzi and Paolo Borrione and Yannis Pitsiladis",
year = "2019",
month = "4",
day = "1",
doi = "10.1249/JSR.0000000000000577",
language = "English",
volume = "18",
pages = "97--104",
journal = "Current Sports Medicine Reports",
issn = "1537-890X",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Altitude Training and Recombinant Human Erythropoietin

T2 - Considerations for Doping Detection

AU - Sutehall, Shaun

AU - Muniz-Pardos, Borja

AU - Lima, Giscard

AU - Wang, Guan

AU - Malinsky, Fernanda Rossell

AU - Bosch, Andrew

AU - Zelenkova, Irina

AU - Tanisawa, Kumpei

AU - Pigozzi, Fabio

AU - Borrione, Paolo

AU - Pitsiladis, Yannis

PY - 2019/4/1

Y1 - 2019/4/1

N2 - The benefit of training at altitude to enhance exercise performance remains equivocal although the most widely accepted approach is one where the athletes live and perform lower-intensity running at approximately 2300 m with high-intensity training at approximately 1250 m. The idea is that this method maintains maximal augmentations in total hemoglobin mass while reducing the performance impairment of high-intensity sessions performed at moderate altitude and thus preventing any detraining that can occur when athletes live and train at moderate altitude. This training regimen, however, is not universally accepted and some argue that the performance enhancement is due to placebo and training camp effects. Altitude training may affect an athlete's hematological parameters in ways similar to those observed following blood doping. Current methods of detection appear insufficient to differentiate between altitude training and blood doping making the interpretation of an athlete's biological passport difficult. Further research is required to determine the optimal method for altitude training and to enhance current detection methods to be able to differentiate better blood doping and altitude exposure.

AB - The benefit of training at altitude to enhance exercise performance remains equivocal although the most widely accepted approach is one where the athletes live and perform lower-intensity running at approximately 2300 m with high-intensity training at approximately 1250 m. The idea is that this method maintains maximal augmentations in total hemoglobin mass while reducing the performance impairment of high-intensity sessions performed at moderate altitude and thus preventing any detraining that can occur when athletes live and train at moderate altitude. This training regimen, however, is not universally accepted and some argue that the performance enhancement is due to placebo and training camp effects. Altitude training may affect an athlete's hematological parameters in ways similar to those observed following blood doping. Current methods of detection appear insufficient to differentiate between altitude training and blood doping making the interpretation of an athlete's biological passport difficult. Further research is required to determine the optimal method for altitude training and to enhance current detection methods to be able to differentiate better blood doping and altitude exposure.

UR - http://www.scopus.com/inward/record.url?scp=85064263092&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85064263092&partnerID=8YFLogxK

U2 - 10.1249/JSR.0000000000000577

DO - 10.1249/JSR.0000000000000577

M3 - Article

VL - 18

SP - 97

EP - 104

JO - Current Sports Medicine Reports

JF - Current Sports Medicine Reports

SN - 1537-890X

IS - 4

ER -